🇺🇸 LGND — Ligand Pharmaceuticals Incorporated
Salud Compra fuertePrecio actual
306,20 USD
Máx. histórico
322,75
7 días
Split 1603:1000 del 02/11/2022
Caída desde máximo
-5,13%
Rango 52 semanas
175,89 – 326,63
Variación hoy
+2,41%
Cierre anterior
299,00
Rango de hoy
297,84 – 308,26
Volumen hoy
130.173
Peor caída histórica
-93,34%
06/03/2000 → 19/11/2008
Recuperado en 2694 días
Volatilidad anualizada ⓘ
59,76%
- Nombre completo
- Ligand Pharmaceuticals Incorporated
- Divisa
- USD
- Mercado
- NasdaqGM
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 47
- PER ⓘ
- 122,97 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 351,33 USD (puede no estar actualizado)
- Primera cotización
- 18/11/1992
- Precio actualizado
- hace 8 horas
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for the treatment of immunoglobulin a nephropathy; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also provides Teriparatide injection product for osteoporosis; RYLAZE, a recombinant erwinia asparaginase for acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes in adults and children aged 8 years and older with Stage 2 T1D; and VAXNEUVANCE for the prevention of invasive disease caused by streptococcus pneumoniae serotypes. In addition, it offers Duavee for menopause; Frovatriptan to treat Neurology; FYCOMPA and SESQUIENT for CNS; MEKINIST for cardiology; Nexterone, a captisol-enabled formulation of amiodarone; VEKLURY, an antiviral treatment for COVID-19; and Viviant for osteoporosis. Further, the company develops ACLX-002, Ciforadenant, UGN-301, Viright, MB07133, BOT/BAL, and Lasofoxifene for oncology; Ensifentrine for respiratory disease; QTORIN for rare disease; Sparsentan for kidney disease; VK2809 for hepatology; ANEB-001 for acute cannabinoid intoxication; Reproxalap for opthamology; VK0214 for Rare Disease; and VK5211 for musculoskeletal disorder. The company was incorporated in 1987 and is based in Jupiter, Florida.
| Fecha de pago | Importe por participación |
|---|---|
| 03/04/2007 | 9,3575 USD |
| Fecha | Ratio |
|---|---|
| 02/11/2022 | 1603:1000 |
| 19/11/2010 | 1:6 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 14/06/2019 | 71,00 | 71,00 | 66,85 | 67,01 | -5,60% | 5,84% | 638.956 |
| 13/06/2019 | 69,16 | 71,22 | 68,42 | 70,98 | +3,13% | 4,04% | 422.070 |
| 12/06/2019 | 66,97 | 68,93 | 66,86 | 68,83 | +2,51% | 3,10% | 358.591 |
| 11/06/2019 | 69,68 | 69,71 | 66,20 | 67,14 | -3,45% | 5,04% | 621.483 |
| 10/06/2019 | 71,06 | 71,89 | 69,30 | 69,54 | -1,83% | 3,64% | 331.981 |
| 07/06/2019 | 71,15 | 71,85 | 70,42 | 70,84 | -0,03% | 2,01% | 454.130 |
| 06/06/2019 | 71,02 | 71,43 | 68,95 | 70,86 | -0,13% | 3,49% | 517.448 |
| 05/06/2019 | 71,94 | 72,05 | 70,51 | 70,95 | -0,98% | 2,14% | 354.103 |
| 04/06/2019 | 69,66 | 72,39 | 69,66 | 71,65 | +4,28% | 3,92% | 912.909 |
| 03/06/2019 | 67,89 | 69,34 | 67,68 | 68,71 | +2,58% | 2,44% | 616.193 |
| 31/05/2019 | 68,09 | 68,95 | 66,91 | 66,99 | -2,31% | 3,01% | 531.234 |
| 30/05/2019 | 69,33 | 70,71 | 68,37 | 68,57 | -1,01% | 3,37% | 481.221 |
| 29/05/2019 | 69,78 | 70,21 | 68,65 | 69,27 | -1,37% | 2,23% | 415.658 |
| 28/05/2019 | 70,56 | 71,73 | 70,23 | 70,23 | -0,71% | 2,12% | 328.294 |
| 24/05/2019 | 70,26 | 71,26 | 69,76 | 70,73 | +0,91% | 2,13% | 296.395 |
| 23/05/2019 | 71,02 | 71,35 | 69,29 | 70,09 | -2,13% | 2,91% | 333.905 |
| 22/05/2019 | 70,93 | 72,23 | 70,06 | 71,62 | +0,30% | 3,06% | 347.691 |
| 21/05/2019 | 70,64 | 72,68 | 70,16 | 71,41 | +1,68% | 3,58% | 391.292 |
| 20/05/2019 | 71,00 | 71,21 | 69,56 | 70,23 | -1,83% | 2,33% | 401.231 |
| 17/05/2019 | 71,76 | 72,39 | 69,91 | 71,54 | -1,20% | 3,46% | 409.567 |
| 16/05/2019 | 71,72 | 73,63 | 71,72 | 72,41 | +1,04% | 2,66% | 338.874 |
| 15/05/2019 | 70,29 | 71,90 | 70,00 | 71,67 | +2,02% | 2,70% | 400.750 |
| 14/05/2019 | 70,90 | 71,29 | 70,02 | 70,24 | -0,46% | 1,79% | 438.581 |
| 13/05/2019 | 70,98 | 71,65 | 70,44 | 70,57 | -2,70% | 1,71% | 633.826 |
| 10/05/2019 | 73,76 | 73,77 | 71,67 | 72,53 | -2,31% | 2,85% | 544.860 |
| 09/05/2019 | 74,68 | 75,65 | 72,70 | 74,24 | -1,81% | 3,94% | 541.173 |
| 08/05/2019 | 75,18 | 76,89 | 74,34 | 75,61 | +0,48% | 3,40% | 546.623 |
| 07/05/2019 | 76,53 | 77,27 | 74,55 | 75,25 | -2,62% | 3,55% | 581.729 |
| 06/05/2019 | 73,31 | 77,55 | 71,75 | 77,27 | +1,85% | 7,92% | 826.347 |
| 03/05/2019 | 76,72 | 78,70 | 70,65 | 75,86 | -4,33% | 10,49% | 1.662.792 |